The FDA has received the results of the Nautilus trial, which showed seizure reduction for GTC, determining future clinical trial needs.
1 report, 1 independent
Updated Aug 13
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The FDA has received the results of the Nautilus trial, which showed seizure reduction for GTC, determining future clinical trial needs.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Related events
Coverage
Newest first; wire copies grouped- GuruFocus.comNeuroPace Inc (NPCE) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ... Release Date: August 12, 2025 For the complete transcript of the earnings call, please refer to the full